These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 23269586

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].
    Autrata R, Senková K, Holousová M, Krejcírová I, Dolezel Z, Borek I.
    Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695
    [Abstract] [Full Text] [Related]

  • 3. Unusual adverse choroidal reaction to intravitreal bevacizumab in aggressive posterior retinopathy of prematurity: the Indian Twin Cities ROP screening (ITCROPS) data base report number 7.
    Chhablani J, Rani PK, Balakrishnan D, Jalali S.
    Semin Ophthalmol; 2014 Jul; 29(4):222-5. PubMed ID: 24117452
    [Abstract] [Full Text] [Related]

  • 4. Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan.
    Wu WC, Yeh PT, Chen SN, Yang CM, Lai CC, Kuo HK.
    Ophthalmology; 2011 Jan; 118(1):176-83. PubMed ID: 20673589
    [Abstract] [Full Text] [Related]

  • 5. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
    Kychenthal A, Dorta P.
    Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study.
    Kusaka S, Shima C, Wada K, Arahori H, Shimojyo H, Sato T, Fujikado T.
    Br J Ophthalmol; 2008 Nov; 92(11):1450-5. PubMed ID: 18621796
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.
    Lepore D, Quinn GE, Molle F, Baldascino A, Orazi L, Sammartino M, Purcaro V, Giannantonio C, Papacci P, Romagnoli C.
    Ophthalmology; 2014 Nov; 121(11):2212-9. PubMed ID: 25001158
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.
    Geloneck MM, Chuang AZ, Clark WL, Hunt MG, Norman AA, Packwood EA, Tawansy KA, Mintz-Hittner HA, BEAT-ROP Cooperative Group.
    JAMA Ophthalmol; 2014 Nov; 132(11):1327-33. PubMed ID: 25103848
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.
    Hwang CK, Hubbard GB, Hutchinson AK, Lambert SR.
    Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024
    [Abstract] [Full Text] [Related]

  • 15. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.
    Chung EJ, Kim JH, Ahn HS, Koh HJ.
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1727-30. PubMed ID: 17690897
    [Abstract] [Full Text] [Related]

  • 16. Prospective clinical study of two different treatment regimens of combined laser photocoagulation and intravitreal bevacizumab for retinopathy of prematurity: the Indian Twin Cities ROP Study (ITCROPS) database report number 9.
    Laveti V, Balakrishnan D, Rani PK, Mohamed A, Jalali S.
    Int Ophthalmol; 2020 Dec; 40(12):3539-3545. PubMed ID: 32776299
    [Abstract] [Full Text] [Related]

  • 17. Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels.
    Lee JY, Chae JB, Yang SJ, Yoon YH, Kim JG.
    Graefes Arch Clin Exp Ophthalmol; 2010 Sep; 248(9):1257-62. PubMed ID: 20393741
    [Abstract] [Full Text] [Related]

  • 18. Combined Vitrectomy and Anti-VEGF Treatment for Stage 4 Retinopathy of Prematurity With Extensive Neovascular Proliferation.
    Chandra P, Kumawat D, Agarwal D, Chawla R.
    J Pediatr Ophthalmol Strabismus; 2020 Jan 01; 57(1):61-66. PubMed ID: 31972043
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal bevacizumab monotherapy for retinopathy of prematurity.
    Şahin A, Şahin M, Cingü AK, Çınar Y, Türkcü FM, Yüksel H, Kaya S, Arı Ş, Caça İ.
    Pediatr Int; 2013 Oct 01; 55(5):599-603. PubMed ID: 23659781
    [Abstract] [Full Text] [Related]

  • 20. Ocular complications following treatment in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.
    Morrison D, Shaffer J, Ying GS, Binenbaum G, G-ROP Study Group.
    J AAPOS; 2018 Apr 01; 22(2):128-133. PubMed ID: 29548840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.